{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:03:05Z","timestamp":1790427785030,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.transproceed.2026.07.029","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T11:36:38Z","timestamp":1787139398000},"page":"1510-1520","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk-Stratified 2 mg\/kg ATG Induction in Kidney Transplantation: Comparing Two- and Three-Dose Regimens at a Single Center"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7782-7263","authenticated-orcid":false,"given":"Sunil M.","family":"Kurian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Burgess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8079-4880","authenticated-orcid":false,"given":"Natalia","family":"Orendain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yelena","family":"Figuerado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan S.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randolph L.","family":"Schaffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.transproceed.2026.07.029_bib0001","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/01.tp.0000266677.45428.80","article-title":"Antithymocyte globulin impairs T-cell\/antigen-presenting cell interaction: disruption of immunological synapse and conjugate formation","volume":"84","author":"Haidinger","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2026.07.029_bib0002","doi-asserted-by":"crossref","unstructured":"Michallet MC, Preville X, Flacher M, Fournel S, Genestier L, Revillard JP Functional antibodies to leukocyte adhesion molecules in antithymocyte globulins. Transplantation. 2003; 75(5):657-62. doi:10.1097\/01.TP.0000053198.99206.E6","DOI":"10.1097\/01.TP.0000053198.99206.E6"},{"issue":"5","key":"10.1016\/j.transproceed.2026.07.029_bib0003","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.transproceed.2010.04.019","article-title":"A review of the evidence for use of thymoglobulin induction in renal transplantation","volume":"42","author":"Gaber","year":"2010","journal-title":"Transplant Proc"},{"issue":"1","key":"10.1016\/j.transproceed.2026.07.029_bib0004","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.transproceed.2011.12.063","article-title":"Rabbit antithymocyte globulin compared with basiliximab in kidney transplantation: a single-center study","volume":"44","author":"Kim","year":"2012","journal-title":"Transplant Proc"},{"issue":"1","key":"10.1016\/j.transproceed.2026.07.029_bib0005","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/ajt.13884","article-title":"Induction therapy for kidney transplant recipients: do we still need anti-IL2 receptor monoclonal antibodies?","volume":"17","author":"Hellemans","year":"2017","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.transproceed.2026.07.029_bib0006","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.transproceed.2010.02.088","article-title":"Basiliximab or antithymocyte globulin for induction therapy in kidney transplantation: a meta-analysis","volume":"42","author":"Liu","year":"2010","journal-title":"Transplant Proc"},{"issue":"3","key":"10.1016\/j.transproceed.2026.07.029_bib0007","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/sj.bmt.1704758","article-title":"Antilymphocyte\/thymocyte globulin for graft versus host disease prophylaxis: efficacy and side effects","volume":"35","author":"Bacigalupo","year":"2005","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.transproceed.2026.07.029_bib0008","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/01.tp.0000179639.98338.39","article-title":"Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression","volume":"80","author":"Caillard","year":"2005","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.transproceed.2026.07.029_bib0009","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1086\/597089","article-title":"Infectious complications of antilymphocyte therapies in solid organ transplantation","volume":"48","author":"Issa","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.transproceed.2026.07.029_bib0010","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1517\/14712598.2013.822064","article-title":"A review on comparing two commonly used rabbit anti-thymocyte globulins as induction therapy in solid organ transplantation","volume":"13","author":"Gharekhani","year":"2013","journal-title":"Expert Opin Biol Ther"},{"issue":"5","key":"10.1016\/j.transproceed.2026.07.029_bib0011","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.transproceed.2010.04.017","article-title":"Is there any role for antithymocyte induction in renal transplantation?","volume":"42","author":"Neidlinger","year":"2010","journal-title":"Transplant Proc"},{"issue":"2","key":"10.1016\/j.transproceed.2026.07.029_bib0012","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000000765","article-title":"Tailored rabbit antithymocyte globulin induction dosing for kidney transplantation","volume":"4","author":"Singh","year":"2018","journal-title":"Transplant Direct"},{"issue":"4","key":"10.1016\/j.transproceed.2026.07.029_bib0013","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.trim.2012.02.003","article-title":"The effect of low and ultra-low dosages thymoglobulin on peripheral T, B and NK cells in kidney transplant recipients","volume":"26","author":"Kho","year":"2012","journal-title":"Transpl Immunol"},{"issue":"14","key":"10.1016\/j.transproceed.2026.07.029_bib0014","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1007\/s40265-014-0277-6","article-title":"New directions for rabbit antithymocyte globulin (Thymoglobulin(R)) in solid organ transplants, stem cell transplants and autoimmunity","volume":"74","author":"Mohty","year":"2014","journal-title":"Drugs"},{"issue":"7","key":"10.1016\/j.transproceed.2026.07.029_bib0015","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/TP.0b013e3181b6f38c","article-title":"Reduced dose rabbit anti-thymocyte globulin induction for prevention of acute rejection in high-risk kidney transplant recipients","volume":"88","author":"Klem","year":"2009","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.transproceed.2026.07.029_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104408","article-title":"Immunophenotyping and efficacy of low dose ATG in non-sensitized kidney recipients undergoing early steroid withdrawal: a randomized pilot study","volume":"9","author":"Grafals","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.transproceed.2026.07.029_bib0017","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.ekir.2021.01.007","article-title":"Low-dose antithymocyte globulin has no disadvantages to standard higher dose in pediatric kidney transplant recipients: report from the pediatric nephrology research consortium","volume":"6","author":"Ashoor","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"10","key":"10.1016\/j.transproceed.2026.07.029_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0240929","article-title":"Induction therapy in kidney transplant recipients: Description of the practices according to the calendar period from the French multicentric DIVAT cohort","volume":"15","author":"Boucquemont","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.transproceed.2026.07.029_bib0019","doi-asserted-by":"crossref","DOI":"10.1177\/2054358120964061","article-title":"Incidence, risk factors, and outcomes of kidney transplant recipients treated with both basiliximab and antithymocyte globulin","volume":"7","author":"Jeong","year":"2020","journal-title":"Can J Kidney Health Dis"},{"issue":"9","key":"10.1016\/j.transproceed.2026.07.029_bib0020","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/00007890-200211150-00014","article-title":"Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors","volume":"74","author":"Port","year":"2002","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.transproceed.2026.07.029_bib0021","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/00007890-199001000-00020","article-title":"Influence of cadaver donor age on posttransplant renal function and graft outcome","volume":"49","author":"Rao","year":"1990","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.transproceed.2026.07.029_bib0022","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/ajt.13043","article-title":"Comparison of longer-term outcomes after kidney transplantation between Hispanic and non-Hispanic whites in the United States","volume":"15","author":"Arce","year":"2015","journal-title":"Am J Transplant"},{"issue":"7","key":"10.1016\/j.transproceed.2026.07.029_bib0023","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1097\/01.tp.0000173379.53347.31","article-title":"Race\/ethnicity, poverty status, and renal transplant outcomes","volume":"80","author":"Press","year":"2005","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.transproceed.2026.07.029_bib0024","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.transproceed.2024.02.028","article-title":"The value of protocol biopsy in kidney transplantation on monitoring transplant outcomes: a systematic review and meta-analysis","volume":"56","author":"Garcia-Lopez","year":"2024","journal-title":"Transplant Proc"},{"issue":"6","key":"10.1016\/j.transproceed.2026.07.029_bib0025","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.kint.2022.07.030","article-title":"Long-term immunological outcomes of early subclinical inflammation on surveillance kidney allograft biopsies","volume":"102","author":"Mehta","year":"2022","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.transproceed.2026.07.029_bib0026","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.kint.2020.04.052","article-title":"The meaning of borderline rejection in kidney transplantation","volume":"98","author":"Nankivell","year":"2020","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.transproceed.2026.07.029_bib0027","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.kint.2022.10.026","article-title":"Transitional B cell cytokines risk stratify early borderline rejection after renal transplantation","volume":"103","author":"Cherukuri","year":"2023","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.transproceed.2026.07.029_bib0028","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14019","article-title":"Treatment of borderline infiltrates with minimal inflammation in kidney transplant recipients has no effect on allograft or patient outcomes","volume":"34","author":"Dale","year":"2020","journal-title":"Clin Transplant"},{"issue":"12","key":"10.1016\/j.transproceed.2026.07.029_bib0029","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1097\/TP.0000000000002327","article-title":"Impact of the current versus the previous diagnostic threshold on the outcome of patients with borderline changes suspicious for T cell-mediated rejection diagnosed on indication biopsies","volume":"102","author":"McRae","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2026.07.029_bib0030","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/957549","article-title":"Thymoglobulin induction dosing strategies in a low-risk kidney transplant population: three or four days?","volume":"2010","author":"Hardinger","year":"2010","journal-title":"J Transplant"},{"issue":"5","key":"10.1016\/j.transproceed.2026.07.029_bib0031","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0251384","article-title":"The influence of the antithymocyte globulin dose on clinical outcomes of patients undergoing kidney retransplantation","volume":"16","author":"Linhares","year":"2021","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.transproceed.2026.07.029_bib0032","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/01.tp.0000165847.05787.08","article-title":"A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring","volume":"80","author":"Ciancio","year":"2005","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.transproceed.2026.07.029_bib0033","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1016\/j.transproceed.2010.08.045","article-title":"Randomized trial of thymoglobulin versus alemtuzumab (with lower dose maintenance immunosuppression) versus daclizumab in living donor renal transplantation","volume":"42","author":"Ciancio","year":"2010","journal-title":"Transplant Proc."},{"issue":"6","key":"10.1016\/j.transproceed.2026.07.029_bib0034","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1097\/00007890-200109270-00012","article-title":"Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression","volume":"72","author":"Mourad","year":"2001","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.transproceed.2026.07.029_bib0035","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/01.TP.0000056635.59888.EF","article-title":"A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients","volume":"75","author":"Charpentier","year":"2003","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.transproceed.2026.07.029_bib0036","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1432-2277.2004.00047.x","article-title":"ATG induction therapy: long-term effects on Th1 but not on Th2 responses","volume":"18","author":"Weimer","year":"2005","journal-title":"Transpl Int."},{"issue":"9","key":"10.1016\/j.transproceed.2026.07.029_bib0037","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14372","article-title":"A call for transplant stewardship: the need for expanded evidence-based evaluation of induction and biologic-based cost-saving strategies in kidney transplantation and beyond","volume":"35","author":"Jorgenson","year":"2021","journal-title":"Clin Transplant"},{"issue":"8","key":"10.1016\/j.transproceed.2026.07.029_bib0038","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/phar.1624","article-title":"Evaluation of a weight-based rabbit anti-thymocyte globulin induction dosing regimen for kidney transplant recipients","volume":"35","author":"Pennington","year":"2015","journal-title":"Pharmacotherapy"},{"issue":"4","key":"10.1016\/j.transproceed.2026.07.029_bib0039","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/TP.0b013e318257ad1a","article-title":"Impact of small variations in the delivered dose of rabbit antithymocyte induction therapy in kidney transplantation with early corticosteroid withdrawal","volume":"94","author":"Tsapepas","year":"2012","journal-title":"Transplantation"},{"issue":"23","key":"10.1016\/j.transproceed.2026.07.029_bib0040","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.2146\/ajhp110120","article-title":"Clinical and economic analysis of short-course versus standard-course antithymocyte globulin (rabbit) induction therapy in deceased-donor renal transplant recipients","volume":"68","author":"Marfo","year":"2011","journal-title":"Am J Health Syst Pharm."},{"issue":"7","key":"10.1016\/j.transproceed.2026.07.029_bib0041","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S1083-8791(03)00127-7","article-title":"Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantation","volume":"9","author":"Waller","year":"2003","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004113452600391X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004113452600391X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:50:54Z","timestamp":1790427054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004113452600391X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S004113452600391X"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2026.07.029","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk-Stratified 2 mg\/kg ATG Induction in Kidney Transplantation: Comparing Two- and Three-Dose Regimens at a Single Center","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2026.07.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}